Holen Sie sich die Stockscreener-App
42.04
3.49%
-1.52
Handel nachbörslich:
42.00
-0.04
-0.10%
Schlusskurs vom Vortag:
$43.56
Offen:
$43.78
24-Stunden-Volumen:
1.13M
Relative Volume:
1.29
Marktkapitalisierung:
$3.32B
Einnahmen:
$399.58M
Nettoeinkommen (Verlust:
$-54.04M
KGV:
-56.05
EPS:
-0.75
Netto-Cashflow:
$40.13M
1W Leistung:
-0.83%
1M Leistung:
-4.11%
6M Leistung:
+55.24%
1J Leistung:
-3.97%
1-Tages-Spanne:
$41.96
$44.34
1-Wochen-Bereich:
$41.96
$46.76
52-Wochen-Spanne:
$22.61
$50.71
Veracyte Inc Stock (VCYT) Company Profile
Firmenname
Veracyte Inc
Sektor
Branche
Telefon
(650) 243-6300
Adresse
6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA
Vergleichen Sie VCYT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VCYT
Veracyte Inc
|
42.04 | 3.44B | 399.58M | -54.04M | 40.13M | -0.75 |
|
TMO
Thermo Fisher Scientific Inc
|
618.86 | 227.87B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
238.37 | 165.99B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
713.35 | 56.89B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
148.52 | 41.32B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
IQV
Iqvia Holdings Inc
|
242.41 | 41.42B | 15.90B | 1.28B | 2.21B | 7.2842 |
Veracyte Inc Stock (VCYT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Underweight |
| 2025-10-20 | Eingeleitet | Canaccord Genuity | Hold |
| 2025-03-20 | Eingeleitet | Craig Hallum | Buy |
| 2024-12-05 | Herabstufung | Goldman | Buy → Neutral |
| 2024-11-15 | Eingeleitet | Wolfe Research | Outperform |
| 2024-10-16 | Eingeleitet | UBS | Buy |
| 2024-10-10 | Eingeleitet | Guggenheim | Buy |
| 2024-02-23 | Bestätigt | Needham | Buy |
| 2023-01-18 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-01-05 | Eingeleitet | Scotiabank | Sector Outperform |
| 2022-01-07 | Eingeleitet | Stephens | Overweight |
| 2021-11-18 | Fortgesetzt | Goldman | Buy |
| 2021-06-15 | Eingeleitet | Raymond James | Outperform |
| 2021-02-18 | Fortgesetzt | Needham | Buy |
| 2021-01-28 | Eingeleitet | Truist | Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-09-09 | Eingeleitet | Morgan Stanley | Underweight |
| 2019-07-31 | Eingeleitet | Lake Street | Buy |
| 2019-07-02 | Eingeleitet | Needham | Buy |
| 2018-11-29 | Herabstufung | Janney | Buy → Neutral |
| 2018-10-31 | Hochstufung | Janney | Neutral → Buy |
| 2017-11-07 | Herabstufung | Janney | Buy → Neutral |
| 2017-11-07 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-08-31 | Fortgesetzt | BTIG Research | Buy |
| 2016-11-14 | Fortgesetzt | Leerink Partners | Outperform |
| 2015-12-18 | Eingeleitet | Cantor Fitzgerald | Buy |
| 2015-06-11 | Bestätigt | Leerink Partners | Outperform |
| 2013-11-26 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Veracyte Inc Aktie (VCYT) Neueste Nachrichten
Can Veracyte Inc. (12V) stock reach $200 price targetJuly 2025 Weekly Recap & AI Driven Price Predictions - ulpravda.ru
Why Veracyte Inc. stock could outperform in 2025July 2025 Decliners & Low Risk Growth Stock Ideas - ulpravda.ru
Veracyte Inc (VCYT) Stock Price Today | Live Chart & News - Traders Union
Will Veracyte Inc. stock gain from lower inflationJuly 2025 Outlook & Daily Chart Pattern Signal Reports - ulpravda.ru
What analyst consensus says on Veracyte Inc. stockTrade Exit Report & Short-Term Swing Trade Alerts - ulpravda.ru
Update Recap: How interest rate cuts could boost Veracyte Inc. stock2025 Analyst Calls & Technical Pattern Based Signals - ulpravda.ru
Aug Chart Watch: How interest rate cuts could boost Veracyte Inc. stockMarket Growth Report & Verified Swing Trading Watchlists - ulpravda.ru
EBITDA per share of Veracyte, Inc. – DUS:12V - TradingView — Track All Markets
User | poteaudailynews.comVeracyte, Inc.Common Stock (Nasdaq:VCYT) Stock Quote - FinancialContent
Morgan Stanley initiates coverage of Veracyte, Inc. (VCYT) - MSN
Is this the right time to add Veracyte stock to your portfolio? - MSN
Veracyte price target raised to $50 from $45 at Guggenheim - MSN
Here's Why You Should Retain Masimo Stock in Your Portfolio Now - Finviz
Guggenheim Raises Price Target for Veracyte (VCYT) to $50.00 | V - GuruFocus
Veracyte (VCYT): Assessing Whether Recent Momentum Justifies Its Current Valuation - Yahoo Finance
The Truth About Veracyte Inc (VCYT): Silent Biotech Stock That Could Blow Up Your Portfolio - AD HOC NEWS
What analysts say about Veracyte Inc stockMACD Histogram Signals & Low Risk Portfolio Growth - earlytimes.in
Yousif Capital Management LLC Takes Position in Veracyte, Inc. $VCYT - MarketBeat
Investment Review: How interest rate cuts could boost Veracyte Inc stock2025 Trade Ideas & Safe Entry Zone Tips - moha.gov.vn
Smart Oncology: 5 Stocks Chasing the $317B Prize - Cantech Letter
Morgan Stanley Initiates Coverage Of Veracyte, Inc. (VCYT) - Yahoo Finance
Zacks Industry Outlook Highlights Veracyte, IDEXX Laboratories and Intuitive Surgical - sharewise.com
Is This the Right Time to Add Veracyte Stock to Your Portfolio? - Eastern Progress
Veracyte to Participate in the 44th Annual J.P. Morgan Healthcare Conference - 01net
3 Medical Instrument Stocks to Counter Industry Woes Using GenAI - sharewise.com
12 Best Genomics Stocks to Invest In - Insider Monkey
Veracyte (NASDAQ:VCYT) Raised to Strong-Buy at Wall Street Zen - MarketBeat
Veracyte, Inc. $VCYT Shares Sold by Assenagon Asset Management S.A. - MarketBeat
Published on: 2025-12-25 21:43:38 - moha.gov.vn
Veracyte Earnings Notes - Trefis
Why Veracyte Inc. (12V) stock remains top rated2025 Pullback Review & High Accuracy Swing Trade Signals - Улправда
How Veracyte Inc. stock benefits from global expansion2025 Investor Takeaways & Weekly Watchlist for Consistent Profits - Улправда
How analysts rate Veracyte Inc. stock todayCPI Data & Safe Swing Trade Setup Alerts - Улправда
Layoff Watch: Is Veracyte Inc. stock a top pick in earnings seasonTrade Performance Summary & Daily Profit Focused Stock Screening - Улправда
Is Veracyte Inc. stock a top pick in earnings season2025 Price Momentum & Trade Opportunity Analysis - Улправда
Fed Meeting: Why Veracyte Inc. stock could outperform in 2025Short Setup & Target Return Focused Stock Picks - DonanımHaber
Will Veracyte Inc. stock attract more institutional investorsWeekly Stock Summary & Low Drawdown Momentum Ideas - Улправда
Can Veracyte Inc. stock weather global recessionMarket Growth Summary & Low Risk Profit Maximizing Plans - Улправда
Can Veracyte Inc. stock deliver strong Q4 earningsIPO Watch & Detailed Earnings Play Strategies - Улправда
CEO Change: Is Veracyte Inc. stock a top pick in earnings seasonDividend Hike & Accurate Trade Setup Notifications - Улправда
Is Veracyte, Inc. (NASDAQ:VCYT) Trading At A 30% Discount? - Yahoo Finance
Rep. Gilbert Ray Cisneros, Jr. Sells Off Shares of Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
Finanzdaten der Veracyte Inc-Aktie (VCYT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.12%
0.03%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):